SCHEMBL27780871

SCHEMBL27780871

O=C(O)CCCc1cccc(CC(=O)O)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.66
HDAC3 O15379 1/20 0.66
MAPK1 P28482 1/20 0.66
ADRA1A P35348 1/20 0.66
HDAC4 P56524 1/20 0.66
SLC6A3 Q01959 1/20 0.66
HDAC1 Q13547 1/20 0.66
HDAC7 Q8WUI4 1/20 0.66
HDAC2 Q92769 1/20 0.66
HDAC10 Q969S8 1/20 0.66
HDAC11 Q96DB2 1/20 0.66
HDAC8 Q9BY41 1/20 0.66
HDAC6 Q9UBN7 1/20 0.66
HDAC9 Q9UKV0 1/20 0.66
HDAC5 Q9UQL6 1/20 0.66
CYP1A2 P05177 2/20 0.57
MAPT P10636 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25342051 0.92 HDAC3 (0.76) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL4407150 0.89 KEAP1 (0.63) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL30638471 0.89 KEAP1 (0.63) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL4402323 0.86 AKR1B1 (0.62) CYP1A2MAPTCYP2C19AKR1B1FFAR1
SCHEMBL27712159 0.85 SMN1; SMN2 (0.66) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL1197247 0.85 MAPT (0.78) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
Phenylbutanoic Acid SCHEMBL7703557 0.85 HDAC1 (0.84) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL70565 0.84 AKR1B1 (0.71) CYP1A2MAPTCYP2C19AKR1B1GLS
SCHEMBL1666941 0.84 SMN1; SMN2 (0.63) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4
SCHEMBL29009897 0.84 SMN1; SMN2 (0.63) SMN1; SMN2HDAC3MAPK1ADRA1AHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101663284-A Macrocyclic compounds as hcv ns3 protease inhibitors NOVARTIS AG 2010-03-03 CN disclosed